Jiangxi Xinganjiang Pharmaceutical Co., Ltd. (Stock Code: 873167) is a comprehensive pharmaceutical enterprise established in 2004 that integrates the production of raw drugs and Chinese and Western pharmaceutical preparations, and is a national high technology enterprise, a provincial private technology enterprise in Jiangxi Province. Since its establishment, "" quality as a dimension, credibility as an edge, pioneering effort, and pragmatic innovation "" has been regarded as the corporate culture concept of our company. Take full advantage of the brand advantage of the former Jiangxi Ganjiang Pharmaceutical Co., Ltd. to play the leading idea of science and technology as a lead, then develop and put into production of several dosage forms including nationwide exclusive variety - chisao Qiang bone capsule, only two produced varieties - compound Forsythia aminosensitive capsule, and other capsules, tablets, granules, dispersions, spindles, raw materials and other dosage forms. VC tablets, VB1 tablets, ranitidine capsules, Bushen tonic capsules, phenol cafinitrina tablets, Curcumol pentopromazine granules, calcium gluconate, zinc gluconate, ferrous gluconate and other 163 drug products are approved by the "" Chinese pharmaceutical standard "" approval number. Due to the high credibility of product quality, the crude drugs are sold abroad, and the Chinese and Western pharmaceutical preparations have formed a large sales network in the country. 310 existing employees of the company. The company has a sales force that is rigorously trained and evaluated with expertise in marketing and a group of front-line manufacturing workers with expertise in skilled manufacturing as well as QA and QC teams in the Department of quality control. The company is located at 36 Yunzhang Road, Jizhou District, Ji'an City, Jiangxi, China. The company has a footprint of 980000 square meters and a building area of 480000 square meters, of which: room for production is 380000 square meters, storage is 9000 square meters, room for quality detection is 1900 square meters, and room for production is 38000 square meters. More than 600 units (sets) of the company's existing production equipment, and the company's annual production capacity is: 5000 tons of drug substance, 2 billion tablets, 800 million capsules, and 100 million packages of granules. A strict quality assurance system is a reliable guarantee of the company's quality, and the company's quality control department is fully equipped, with 1 Infrared chromatograph, 1 thin-layer scanner, 4 high-performance liquid chromatograph, 2 atomic absorption chromatograph, 1 gas chromatograph, products all project full detection plants. The company was certified by GMP in November 2004, the large family with tax increment was obtained in February 2005, the class B tax credit enterprise was obtained in March 2006, the integrity tax enterprise was obtained in April 2007, the class AAA credit enterprise was obtained in March 2008, the ten best players enterprise in Jizhou district was obtained in January 2009, the national industrial product production license was obtained in July 2009, the drug production license was obtained in June 2011, Received 2 provincial key new product titles in February 2012, identified through high and new technology enterprises in December 2013, and recognized as provincial private science and technology-based enterprises in December 2013, receiving 3 invention patents and 5 utility model patents. The year contribution award was awarded for three consecutive years, February 2008, February 2009 and February 2010, with the honor of A-class payers and others in July 2014. All products of the company in 2015 are certified by (2010 Edition) GMP. The company will hold a foothold and look out to the world, and facing new opportunities and challenges, Jiangxi new Ganjiang Pharmaceutical Co., Ltd. will constantly pursue it, making its due contribution to human health and the healthy development of the pharmaceutical career in the home country.